Medical Weight Loss, Modernized

GLP-1 medications have changed what’s possible—but the best outcomes come from a physician-led program: thoughtful medication selection, smart titration, side-effect strategy, and a muscle-preserving plan that actually fits real life.

⚡ Evidence-led medication strategy 🧠 Appetite + cravings quieted 💪 Fat loss + muscle protection 🫀 Cardiometabolic risk focus

● Concierge-level follow-up & coaching

What Modern Medications Can Deliver

With the right patient selection and consistent follow-up, GLP-1–based therapies can produce substantial, clinically meaningful weight loss— while improving blood sugar patterns, blood pressure, and lipid risk in many patients.

10–15%

Typical GLP-1 range

Many patients, with program support

15–22%

Dual-incretin range

Selected patients, optimized dosing

↓ Cravings

The “food noise” effect

Often felt early in treatment

↓ Risk

Cardiometabolic focus

Labs + blood pressure often improve

It’s not willpower. These medications treat appetite biology and satiety signaling.
Consistency is the superpower. The “best” dose is the lowest dose that creates steady progress with tolerable side effects.
We don’t chase the scale alone. Protein targets + resistance training protect lean mass and energy.
Follow-up matters. Adjustments to dosing, nutrition, and symptoms are what keep results moving.

Your Physicians (And Your Plan)

Medication is one tool. The difference is how it’s prescribed, monitored, and integrated into a complete medical plan.

Your Physician Team

Internal Medicine • Metabolic Health • Prevention

We focus on safe weight loss that improves healthspan: blood pressure, insulin resistance, fatty liver risk, sleep, inflammation, and long-term cardiovascular risk—not just a number on the scale.

Structured titration Side-effect playbook Muscle protection

High-Touch Follow-Up

Concierge-style availability • Coaching • Accountability

Rapid access, quick adjustments, and practical guidance: what to eat when appetite drops, how to avoid GI setbacks, and how to keep energy strong while weight is coming off.

Nutrition targets Medication optimization Sustainable habits

A Program Built Around Real Life

We combine modern pharmacotherapy with a simple, repeatable approach: medication titration + protein + strength training + sleep strategy + lab-driven targets. You’ll know exactly what to do when appetite changes, when plateaus happen, and how to keep results stable long-term.

Week 1–4: appetite & side-effect strategy, hydration/fiber, protein foundation
Weeks 4–12: dose refinement + training routine + craving triggers
Ongoing: maintenance plan, labs, and metabolic risk optimization

Modern Family Medicine

A calm, private setting—built for unhurried, personalized care.

Medication Options (How We Think About Them)

Different medications fit different profiles. We match the tool to your goals, medical history, appetite pattern, and tolerability— then adjust dosing with a physician’s eye.

GLP-1 medications

Core class

Best for appetite control, satiety, and consistency

Often improves cravings and portion size naturally
May improve glycemic patterns and cardiometabolic markers
Titration speed is individualized to minimize GI side effects

Dual-incretin therapy

Higher efficacy

Selected patients targeting larger weight-loss goals

Often produces greater average weight loss in trials
Excellent option when insulin resistance patterns dominate
Requires thoughtful escalation and symptom planning

Adjunct medications

Situational

Non-GLP-1 tools for specific appetite or risk profiles

May help when GLP-1 therapy isn’t appropriate
Can be considered to support plateaus in selected cases
Choice depends on BP, sleep, mood history, and goals

What’s new & emerging

Pipeline

Oral agents, combinations, and multi-pathway approaches

Oral GLP-1 programs (including small molecules) are expanding rapidly
Combination therapies aim to raise efficacy and improve satiety profiles
Ongoing studies define long-term safety, tolerability, and best use cases

Ready for a Real Plan?

If you’re done guessing, we’ll build a physician-led strategy: medication selection (if appropriate), a side-effect playbook, a nutrition framework that works with appetite changes, and a muscle-preserving training plan.

Book a Consultation Learn About Concierge Care

Frequently Asked Questions

Simple answers to the questions patients ask most—without the hype.

Q How fast will I lose weight?

Most patients see appetite changes early, but the most meaningful weight loss typically builds over the first 8–16 weeks as dosing is optimized. The goal is steady progress that protects energy and lean mass.

Q Will I have to take medication forever?

Obesity behaves like a chronic disease with a biologic tendency toward regain. Some patients choose a maintenance strategy; others taper with a structured plan. We decide based on your results, risk profile, and long-term goals.

Q What about nausea or constipation?

This is where physician guidance matters: slower titration when needed, meal timing strategies, hydration and fiber targets, and a clear protocol for common GI side effects.

Q How do you prevent muscle loss?

We emphasize protein targets and resistance training. Weight loss is not the only goal—body composition is. A program without muscle protection can reduce strength, energy, and metabolic rate.

Q Is it safe?

Safety depends on appropriate screening, contraindication review, monitoring, and individualized dosing. We also focus on medication integrity—avoiding unverified sources. Your plan is built around your medical history and goals.

Educational content only. Medication choice, dosing, and monitoring should be individualized.

Selected Clinical References

For transparency, here are several cornerstone trials often cited in modern medical weight-loss discussions.

STEP-1 (semaglutide 2.4 mg): https://pubmed.ncbi.nlm.nih.gov/33567185/
SURMOUNT-1 (tirzepatide): https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
SELECT (semaglutide cardiovascular outcomes): https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
General safety/labeling (FDA): https://www.fda.gov/drugs

New therapies and indications evolve quickly; we align recommendations with current FDA labeling and high-quality evidence.